This article is part of Life Sciences Review's Innovation Insights series featuring expert contributions nominated by our subscribers and reviewed by our editorial team.
Based in Frankfurt, Germany, the privately-owned company is driven by medical scientists and experts. Trilogy strives to provide the highest quality of writing in the shortest period of time. Every document produced by Trilogy is easy to understand and review, and tailored according to its target audience. The clear and concise medical writing significantly minimises the queries arising from regulatory assessors, prescribers, or patients. As a matter of fact, Trilogy also goes the extra mile in ensuring that drug approval and establishment are achieved at the quickest.
With Trilogy, the sponsors can rest assured of having the highest quality of documentation that is accurate as well as written to impress the regulators. In the interest of the safety of all concerned, medical therapies around the world are highly regulated. Before any new treatment is introduced into the market, it undergoes the most rigorous clinical trials.
Every document produced by Trilogy is easy to understand and review, and tailored according to its target audience
To understand Trilogy’s unique process, we can explore how the company helps its clients in expediting their clinical development process. Firstly, the company assigns a dedicated writing team, which assists the client’s clinical development group with its robust medical writing, project management, and quality control capabilities. To reduce document preparation time, Trilogy’s team conducts parallel processing of different sections of the document. As the process is supported by an entire team rather than an individual writer, Trilogy delivers continuous upkeep throughout the development process. Furthermore, the complementary skills and experiences of the team members strengthen the integrity and quality of the medical documentation, thus helping the clients overcome the regulatory challenges.
As a flexible and responsive company, Trilogy continuously adapts its approaches to counter the uncertainties involved in clinical development. By consolidating the diverse functions of the clinical development through the documentation process, Trilogy facilitates seamless coordination between the various teams involved in clinical development. The company is set to expand its capabilities further and augment its footing in the medical space. Trilogy is on the path of redefining medical writing, not only for the benefits of its clients but also for other stakeholders relevant to clinical development.
The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.